KENILWORTH, N.J. – Merck & Co. is reporting a third-quarter loss of $56 million after a profit in the same period a year earlier, but it still beat Wall Street expectations.
Continue Reading Below
The Kenilworth, New Jersey, on Friday posted a loss of 2 cents per share. Earnings, adjusted for non-recurring costs, were $1.11 per share. That’s 8 cents better than industry analysts had forecast, according to a survey by Zacks Investment Research.
The pharmaceutical company posted revenue of $10.33 billion in the period, shy of expectations.
Merck expects full-year earnings in the range of $3.91 to $3.97 per share, with revenue in the range of $40 billion to $40.5 billion.
_____
This story was generated by Automated Insights using data from Zacks Investment Research. Access a Zacks stock report on MRK at https://www.zacks.com/ap/MRK
